Woodside Energy Group Ltd
WDS
Westpac Banking Corp
WBC
Telstra Group Ltd
TLS
Rio Tinto Ltd
RIO
Origin Energy Ltd
ORG
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.